Rafferty Asset Management, LLC Kura Oncology, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 91,737 shares of KURA stock, worth $986,172. This represents 0.01% of its overall portfolio holdings.

Number of Shares

91,737

Previous 124,585 26.37%

Holding current value

$986,172

Previous $2.57 Million 30.14%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$18.57 - $23.23 $609,987 - $763,059	-32,848 Reduced 26.37%	91,737 $1.79 Million
Q2 2024 Aug 13, 2024	SELL	$17.53 - $22.98 $3.27 Million - $4.29 Million	-186,683 Reduced 59.98%	124,585 $2.57 Million
Q1 2024 May 13, 2024	BUY	$13.42 - $23.53 $2.15 Million - $3.76 Million	159,994 Added 105.76%	311,268 $6.64 Million
Q4 2023 Feb 13, 2024	SELL	$7.58 - $14.38 $613,472 - $1.16 Million	-80,933 Reduced 34.85%	151,274 $2.18 Million
Q3 2023 Nov 13, 2023	BUY	$8.44 - $11.86 $291,804 - $410,047	34,574 Added 17.49%	232,207 $2.12 Million
Q2 2023 Aug 11, 2023	SELL	$9.62 - $13.99 $739,980 - $1.08 Million	-76,921 Reduced 28.02%	197,633 $2.09 Million
Q1 2023 May 11, 2023	SELL	$10.71 - $14.6 $571,528 - $779,114	-53,364 Reduced 16.27%	274,554 $3.36 Million
Q4 2022 Feb 13, 2023	BUY	$11.23 - $16.9 $516,624 - $777,467	46,004 Added 16.32%	327,918 $4.07 Million
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $2.24 Million - $3.63 Million	186,640 Added 195.9%	281,914 $3.85 Million
Q2 2022 Aug 12, 2022	SELL	$10.71 - $18.33 $919,014 - $1.57 Million	-85,809 Reduced 47.39%	95,274 $1.75 Million
Q1 2022 May 13, 2022	SELL	$11.78 - $16.98 $328,508 - $473,521	-27,887 Reduced 13.34%	181,083 $2.91 Million
Q4 2021 Feb 10, 2022	BUY	$12.22 - $19.57 $1.12 Million - $1.8 Million	91,758 Added 78.28%	208,970 $2.93 Million
Q3 2021 Nov 10, 2021	BUY	$15.42 - $21.72 $13,322 - $18,766	864 Added 0.74%	117,212 $2.2 Million
Q2 2021 Aug 10, 2021	BUY	$20.85 - $29.88 $71,015 - $101,771	3,406 Added 3.02%	116,348 $2.43 Million
Q1 2021 May 10, 2021	BUY	$24.75 - $39.14 $2.24 Million - $3.54 Million	90,544 Added 404.25%	112,942 $3.19 Million
Q4 2020 Feb 10, 2021	SELL	$29.0 - $41.62 $180,003 - $258,335	-6,207 Reduced 21.7%	22,398 $732,000
Q3 2020 Nov 13, 2020	BUY	$16.3 - $30.64 $262,609 - $493,641	16,111 Added 128.95%	28,605 $876,000
Q2 2020 Aug 07, 2020	BUY	$7.95 - $18.81 $99,327 - $235,012	12,494 New	12,494 $204,000
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $139,003 - $302,576	-21,551 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$12.97 - $15.94 $496,841 - $610,613	-38,307 Reduced 64.0%	21,551 $296,000
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $566,532 - $801,595	38,409 Added 179.07%	59,858 $908,000
Q2 2019 Aug 09, 2019	SELL	$14.71 - $19.79 $133,552 - $179,673	-9,079 Reduced 29.74%	21,449 $422,000
Q1 2019 May 15, 2019	BUY	$13.73 - $16.87 $419,149 - $515,007	30,528 New	30,528 $506,000

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $719M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Kura Oncology, Inc. Transaction History